首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
【24h】

Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.

机译:动作电位实验可完成心脏临床前研究中的hERG测定和QT间隔测量。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: The ICHS7B guideline focused on hERG and QT assays, although other factors have also been linked with the induction of severe arrhythmias. Thus, the aim of the present study was to demonstrate that two in vitro action potential recordings constitute convincing models of predictive drug-induced Torsades de pointes (TdP) and re-entry arrhythmias. METHODS: The effects of D,L-sotalol, flecainide and quinidine were investigated on potassium (hERG) and sodium (Na(V)1.5) currents transfected in HEK-293 cells to determine the repercussion of the blockade of these currents on rabbit Purkinje fibre (PF) and atrial action potentials. Atrial conduction velocity was also investigated as a model of re-entry arrhythmias. RESULTS: hERG channels were blocked by D,L-sotalol, quinidine and flecainide (IC(50): 69, 0.33 and 0.74 micromol/L, respectively). D,L-sotalol (30 micromol/L) induced reverse-use dependent increases in action potential duration (APD(90): +31.7% and +81.2% at 1 and 0.2 Hz) and triangulation (APD(90-40): +34.7% and +73.6% at 1 and 0.2 Hz) in PF but not in atria. Quinidine (10 micromol/L) also increased APD(90) (+14.5% and +68.5% at 1 and 0.2 Hz) and APD(90-40) (+73.3% and +152.1% at 1 and 0.2 Hz) in PF. Flecainide (10 micromol/L) shortened APD(90) in PF (-26.0% and - 22.2% at 1 and 0.2 Hz). Quinidine and flecainide blocked Na(V)1.5 channels by 32.3% and 73.1%, respectively, and produced decreases in dV/dt(max) which were more marked in atria (-20.4% and -31.9%) compared to PF (-12.8% and 22.4%) at 1 Hz. Finally, quinidine and flecainide decreased atrial conduction speed by 14.6% and 30.8%, respectively. CONCLUSION: Results obtained with flecainide demonstrate that use of the hERG channel alone should not be considered as a useful single assay. Rabbit Purkinje fiber action potentials can be considered as a comparable model for detection of reverse-use dependent APD prolongation and triangulation whereas the rabbit atria can be considered as a useful model for detection of sodium channel blockade associated with decreases in dV/dt(max) and conduction velocity.
机译:简介:尽管其他因素也与严重心律不齐的诱发因素相关,但ICHS7B指南侧重于hERG和QT分析。因此,本研究的目的是证明两个体外动作电位记录构成了预测性药物诱发的扭转性扭转性室性心律失常(TdP)和再入心律失常的令人信服的模型。方法:研究了D,L-索他洛尔,氟卡尼和奎尼丁对HEK-293细胞中转染的钾(hERG)和钠(Na(V)1.5)电流的影响,以确定对兔浦肯野的这些电流的阻断作用纤维(PF)和心房动作电位。还研究了心房传导速度作为再入心律不齐的模型。结果:hERG通道被D,L-索他洛尔,奎尼丁和氟卡尼特阻断(IC(50):69、0.33和0.74 micromol / L)。 D,L-索他洛尔(30 micromol / L)引起的反向使用依赖性动作电位持续时间(APD(90):在1和0.2 Hz时分别为+ 31.7%和+ 81.2%)和三角测量(APD(90-40): 1和0.2 Hz时分别为+ 34.7%和+ 73.6%),但在心房中则没有。奎尼丁(10 micromol / L)也会增加PF中的APD(90)(在1和0.2 Hz时为+ 14.5%和+ 68.5%)和APD(90-40)(在1和0.2 Hz时为+ 73.3%和+ 152.1%) 。 Flecainide(10 micromol / L)缩短了PF中的APD(90)(在1和0.2 Hz时为-26.0%和-22.2%)。奎尼丁和氟卡尼特分别阻断Na(V)1.5通道32.3%和73.1%,并导致dV / dt(max)降低,与PF(-12.8)相比,其心房(-20.4%和-31.9%)更为明显%和22.4%)在1 Hz。最后,奎尼丁和氟卡尼使心房传导速度分别降低14.6%和30.8%。结论:使用氟卡尼获得的结果表明,单独使用hERG通道不应被视为有用的单一检测方法。兔浦肯野纤维动作电位可被视为检测反向使用依赖性APD延长和三角测量的可比模型,而兔心房可被视为检测与dV / dt(max)降低相关的钠通道阻滞的有用模型和传导速度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号